Literature DB >> 2282952

Correlation between conjunctival provocation test (CPT) and systemic allergometric tests in allergic conjunctivitis.

A Leonardi1, I A Fregona, M Gismondi, E Daniotti, G Carniel, A G Secchi.   

Abstract

In order to assess the potential usefulness of CPT as a diagnostic tool for ocular allergy, the correlation between skin/RAST tests and CPT was determined in 144 patients affected by allergic 'hay fever' type conjunctivitis. The results showed that an agreement between skin/RAST tests and CPT occurred in 71% of the cases (130/183). Of the 29% uncorrelated cases, 23% (43/183) were positive for at least one specific antigen by skin/RAST tests but not by CPT, while 6% (10/183) were positive for at least one specific antigen by CPT, but not by skin/RAST tests. CPT dramatically increased the histamine levels in tears (p less than 0.001). These findings show that (1) systemic tests can be misleading in that they may suggest a specific sensitisation which, in fact, does not involve the conjunctiva (systemic test positive/CPT negative); (2) CPT can identify local conjunctival sensitisation in the absence of a systemic sensitisation (systemic test negative/CPT positive); (3) CPT can demonstrate that allergic 'hay fever' type conjunctivitis may be related to allergens different from those responsible for a systemic sensitisation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2282952     DOI: 10.1038/eye.1990.109

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  2 in total

Review 1.  Conjunctival allergen challenge: models in the investigation of ocular allergy.

Authors:  Mark B Abelson; Oliver Loeffler
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

2.  Histamine release test and measurement of antigen-specific IgE antibody in the diagnosis of allergic conjunctival diseases.

Authors:  E Uchio; N Matsuura; S Matsumoto; K Kadonosono; S Ohno
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.